Dicerna Pharmaceuticals, Inc. logo
Dicerna Pharmaceuticals, Inc. DRNA
$ 38.25 0.34%

Dicerna Pharmaceuticals, Inc. Income Statement 2011-2024 | DRNA

Annual Income Statement Dicerna Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.67 B 1.33 B 559 M 211 M 53.9 M 133 M 343 M 765 M - -

Shares

74.5 M 68.4 M 55.6 M 21.9 M 20.7 M 20.3 M 16.1 M 16.6 M - -

Net Income

-113 M -120 M -88.9 M -60 M -59.5 M -62.8 M -47.9 M -18.5 M -10.1 M -8.56 M

Revenue

164 M 23.9 M 6.18 M 2.28 M 295 K 184 K - - 7.02 M 7.91 M

EBITDA

-111 M -127 M -60.4 M -59.8 M -58.9 M -62.3 M -44.3 M -16.9 M -8.7 M -7.14 M

Operating Expenses

278 M 152 M 67.4 M 62.9 M 60 M 63.2 M 45.1 M - - -

General and Administrative Expenses

72.1 M 42.8 M 21.7 M 25.9 M 18.3 M 19.2 M 15.6 M 5.82 M 4.7 M 4.82 M

All numbers in USD currency